Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business Sort ascending
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Sort ascending Functional Area Erscheinungsdatum
Patient Safety Specialist Amiria Ägypten Development Innovative Medicines Research & Development Aug 26, 2024
Tehnolog proizv. inženiringa lokacije za področje avtomatizacije (m/ž/d) / Engineer Multidiscipline - automation area (m/f/d) Mengeš Slowenien Operations Innovative Medicines Technical Operations Aug 27, 2024
Projektni inženir (m/ž/d) / Project Engineer II (m/f/d) Ljubljana Slowenien Operations Innovative Medicines Technical Operations Aug 27, 2024
Allergy-Territory Account Specialist – Green Bay, WI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Aug 27, 2024
RLT Customer Service Coordinator Seoul Südkorea International Innovative Medicines Der Umsatz Aug 27, 2024
Innovative Access Partnerships and Engagement Manager İstanbul Kavacık Türkei International Innovative Medicines Market Access Sep 03, 2024
Group Head, Global Aggregate Reports & Risk Management Barcelona Gran Vía Spanien Development Innovative Medicines Research & Development Aug 29, 2024
Associate Director Data & Digitalization Project Management Schaftenau Österreich Development Innovative Medicines Research & Development Sep 03, 2024
Associate Clinical Research Medical Director - Oncology RLT Remote Position (USA) USA Development Innovative Medicines Research & Development Aug 29, 2024
Customer Engagement &Solution Partner Lithuania Litauen International Innovative Medicines Der Umsatz Aug 29, 2024
Labortechniker / QC Analyst II (m/w/d), Tirol, Österreich Schaftenau Österreich Operations Innovative Medicines Quality Sep 03, 2024
(高级)医药代表 /(资深)产品专员 Xianyang (Shanxi Province) China International Innovative Medicines Der Umsatz Aug 30, 2024
QC Specialist Tech Resources & Compliance Durham USA Operations Innovative Medicines Quality Sep 03, 2024
Senior Clinical Development Medical Director - Renal East Hanover USA Development Innovative Medicines Research & Development Aug 30, 2024
MR Beijing (Beijing) China International Innovative Medicines Der Umsatz Sep 01, 2024
Renal Medical Lead Seoul Südkorea International Innovative Medicines Research & Development Sep 01, 2024
Global Regulatory Publishing Associate London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Systems & Strategy Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Technology Transformation Sep 02, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Österreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Publishing Specialist London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Affairs Process Excellence London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Submission Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Affairs Manager Medical Devices (UK or Austria) London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Policy & Intelligence London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Österreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Labeling Manager Hyderabad (Office) Indien Development Innovative Medicines Research & Development Sep 02, 2024
Intake Specialist INSURGENTES Mexiko US Innovative Medicines Einrichtungen und Verwaltung Sep 02, 2024
Senior Expert, Science & Technology (Analytical Expert) Hyderabad (Office) Indien Development Innovative Medicines Research & Development Sep 03, 2024
Medical Representative - CVRM Mapletree Business City (MBC) Singapur International Innovative Medicines Der Umsatz Sep 02, 2024
Product Steward İstanbul Kurtköy Türkei Operations Innovative Medicines Technical Operations Aug 13, 2024
Project Controller INSURGENTES Mexiko Operations Innovative Medicines Technical Operations Aug 13, 2024
Trial Vendor Senior Manager Hyderabad (Office) Indien Development Innovative Medicines Research & Development Sep 03, 2024
Project Manager Hyderabad (Office) Indien Operations Innovative Medicines Technical Operations Aug 13, 2024
Solution & Service Design Manager London (The Westworks) Vereinigtes Königreich International Innovative Medicines Market Access Aug 15, 2024
QC Specialist I - Analytical Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
QC Specialist II - Analytical Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
Engineering Lead, RLT CN Jiaxing (Zhejiang Province) China Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Analyst - Master Data Management Hyderabad (Office) Indien Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Analyst - Master Data Management Hyderabad (Office) Indien Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Analyst-Master Data Management Hyderabad (Office) Indien Operations Innovative Medicines Technical Operations Aug 19, 2024
Senior Cluster Procurement Manager for Slovenia Ljubljana Slowenien Operations Innovative Medicines Beschaffung Aug 19, 2024
Utilities Maintenance & Reliability Engineer - Site Amiria Ägypten Operations Innovative Medicines Technical Operations Aug 19, 2024
Director HSPD Asset Lead and Expert London (The Westworks) Schweiz International Innovative Medicines Marketing Sep 03, 2024
Project Engineer (Design Phase)_RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Sep 03, 2024
Key Account Manager, Haematology - South West Field Force (England / Wales) Vereinigtes Königreich International Innovative Medicines Der Umsatz Aug 21, 2024
Director, Process Effectiveness & Reporting East Hanover USA US Innovative Medicines Marketing Sep 03, 2024
Site Engineering Head / Directeur Ingénierie et Maintenance (m/f/d) Huningue Frankreich Operations Innovative Medicines Technical Operations Sep 03, 2024
Administrative Expert / Professional RDQ Hyderabad (Office) Indien Development Innovative Medicines Einrichtungen und Verwaltung Aug 22, 2024
(Sr.) Sales Executive-Solid Tumor Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Der Umsatz Aug 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.